{
    "organizations": [],
    "uuid": "7c44d4151e96ed7fa72c8e15ce2cbefd9b8894ce",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/15/the-associated-press-asterias-biotherapeutics-posts-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Asterias Biotherapeutics posts 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "FREMONT, Calif. (AP) _ Asterias Biotherapeutics Inc. (AST) on Thursday reported a loss of $6.5 million in its fourth quarter.\nOn a per-share basis, the Fremont, California-based company said it had a loss of 12 cents.\nThe results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.\nThe stem cell therapy developer posted revenue of $28,000 in the period.\nFor the year, the company reported that its loss narrowed to $28.4 million, or 56 cents per share. Revenue was reported as $4 million.\nIn the final minutes of trading on Thursday, the company's shares hit $1.95. A year ago, they were trading at $3.20.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on AST at https://www.zacks.com/ap/AST",
    "published": "2018-03-16T00:07:00.000+02:00",
    "crawled": "2018-03-16T01:08:00.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "fremont",
        "ap",
        "asterias",
        "biotherapeutics",
        "ast",
        "thursday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "fremont",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "topped",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "stem",
        "cell",
        "therapy",
        "developer",
        "posted",
        "revenue",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "final",
        "minute",
        "trading",
        "thursday",
        "company",
        "share",
        "hit",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "ast",
        "http"
    ]
}